The strengths of this study lies in its large sample size of Chinese patients with early-onset breast cancer who were unselected for other predisposing factors, which allows for an objective reflection of the spectrum and clinicopathological characteristics of PALB2 pathogenic variants in this population. Here, PALB2 is linked to breast cancer.